Lumida
/USPH
⌘K
US Physical Therapy Inc

US Physical Therapy Inc

USPH
$73.56USD-0.85%-0.63 today

MARKET CAP

1.1B

P/E (TTM)

28.3x

FWD P/E

22.9x

DAY RANGE

$73 – $75

52W RANGE

$58
$94

AI Summary

Stalk
StalkMedium

USPH is in a Stage 2 advancing phase within a confirmed uptrend, marked by higher highs and higher lows above rising EMAs. Price is extended above the 9/20 EMA regime and approaching the 200 DMA with extreme overbought readings, suggesting an imminent pullback. We will stalk for a corrective retracement into the 9/20 EMA and 50 DMA support zones before scaling exposure, consistent with a momentum‐oriented execution style.

  • Q1 revenue $198M, +7.9% YoY, driven by hospital partnerships expansion.
  • Average visits per clinic jumped to 32.7/day, net promoter score 93.5.
  • Shares trade at 142.6x P/E, reflecting high valuation vs peers.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

U.S. Physical Therapy, Inc. (NYSE: USPH) is a leading provider of outpatient physical therapy services across the United States, operating a national network of clinics and focusing on rehabilitation and industrial injury prevention. The company has established a market presence through a strategy of acquisition and partnerships, expanding its operational footprint and enhancing service delivery. As healthcare demands increase with an aging population and a rise in injuries across various industries, USPH is strategically positioned to capitalize on these trends while navigating the complexities associated with Medicare reimbursement and competitive pressures.

Bull says

  • Q1 revenue $198M, +7.9% YoY, driven by hospital partnerships expansion.
  • Average visits per clinic jumped to 32.7/day, net promoter score 93.5.
  • AI-assisted documentation roll-out expected to boost clinician productivity and margins.
  • Acquisitions, including Metro, to add ~$14M incremental EBITDA by 2027.
  • Launched $25M share repurchase, balancing capital return with reinvestment in growth.
  • Strong earnings yield and low book-to-price suggest relative undervaluation.

Bear says

  • Shares trade at 142.6x P/E, reflecting high valuation vs peers.
  • Operating margin dropped to 16.1% due to labor costs and weather losses.
  • Negative growth momentum and Medicare rate volatility could pressure revenue sustainability.
  • Elevated leverage increases interest rate sensitivity amid potential borrowing cost rises.
  • Limited institutional ownership and high volatility may dampen stock support.
  • Weak profitability factors signal challenges in maintaining margins under regulatory changes.

Investment themes with USPH

Health Care Providers -0.61%

UNH · CVS · HCA

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-10-2026neutral

Transcript signals

Read full transcript analysis ›